API

Papaverine Hydrochloride is a premier Active Pharmaceutical Ingredient (API) synthesized and manufactured by Parand Darou Co. It functions as a potent antispasmodic and vasodilator, exerting a direct, non-specific relaxant effect on smooth muscle tissue. This API is essential in the formulation of various injectable and oral pharmaceutical products designed to manage vascular and muscular spasms. Mechanism of Action & Clinical Applications Papaverine HCl operates primarily by inhibiting the phosphodiesterase (PDE) enzyme,...

Empagliflozin is a sophisticated Active Pharmaceutical Ingredient (API) belonging to the Sodium-Glucose Co-transporter 2 (SGLT2) inhibitor class, synthesized and manufactured at Parand Darou Co. This innovative therapeutic agent serves as a cornerstone for modern antidiabetic regimens, specifically formulated to achieve optimal glycemic control in patients with Type 2 Diabetes, while providing significant clinical benefits in reducing the risk of cardiovascular events and heart failure. Mechanism of Action & Clinical Advantages جناب...

Sitagliptin Phosphate is a premier Active Pharmaceutical Ingredient (API) belonging to the dipeptidyl peptidase-4 (DPP-4) inhibitor class, synthesized and manufactured by Parand Darou Co. This essential API serves as the therapeutic backbone for oral antidiabetic formulations designed to regulate glycemic levels and optimize metabolic control in patients with Type 2 Diabetes Mellitus. Mechanism of Action & Clinical Advantages Sitagliptin operates through the potent, selective, and competitive inhibition of the DPP-4 enzyme,...

Dapagliflozin Propanediol is a cutting-edge Active Pharmaceutical Ingredient (API) belonging to the Sodium-Glucose Co-transporter 2 (SGLT2) inhibitor class, manufactured at Parand Darou Co. This API, formulated with specific propanediol monohydrate, is essential for the commercial production of medications aimed at optimal glycemic control in patients with Type 2 Diabetes, as well as for reducing the risk of heart failure and preserving renal function. Mechanism of Action & Clinical Advantages Dapagliflozin acts...

Rivaroxaban is a sophisticated Active Pharmaceutical Ingredient (API) categorized as a Direct Oral Anticoagulant (DOAC) and a highly selective Factor Xa inhibitor, manufactured at Parand Darou Co. It acts as a critical raw material for the production of finished dosage forms indicated for the prevention and treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), as well as for stroke prophylaxis in patients with non-valvular atrial fibrillation. Mechanism of...